NA
MED icon

Neuburgh Advisers’s Medifast MED Stock Holding History

Neuburgh Advisers’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$141K Hold
1,364
– – ﹤0.01% 742
2019
Q2 		$175K Hold
1,364
– – 0.01% 717
2019
Q1 		$174K Hold
1,364
– – 0.01% 700
2018
Q4 		$171K Hold
1,364
– – 0.01% 678
2018
Q3 		$302K Buy
1,364
+418
+44% +$84.7K 0.01% 615
2018
Q2 		$152K Buy
+946
New +$121K 0.01% 711

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Neuburgh Advisers's MED Position: Q3 2019 in Review

Neuburgh Advisers held its Medifast (MED) position steady in Q3 2019 at 1,364 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

Neuburgh Advisers first reported a position in MED in Q2 2018 and has held it in 6 quarters since. The position peaked at $302K in Q3 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Neuburgh Advisers held 1,364 shares of Medifast worth $141K as of Q3 2019.
  • Neuburgh Advisers left its Medifast share count unchanged in Q3 2019.
  • Medifast made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #742 holding.
  • Neuburgh Advisers first reported a position in Medifast in Q2 2018 and has held it in 6 quarters since.
  • Neuburgh Advisers's Medifast position peaked at $302K in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.